Malta vs Tajikistan: HIV-positive TB patients on ART (antiretroviral therapy)
Malta
100.0%
in 2023
Tajikistan
100.0%
in 2024
Malta rank
1st
Tajikistan rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Malta
- Tajikistan
How they compare
Malta currently reports 100.0% against 100.0% in Tajikistan, a difference of 0.0%.
The two have swapped places 1 time across 6 shared years of data; in 2007 it was Malta ahead.
Malta ranks 1st and Tajikistan ranks 1st of 144 countries.
Malta has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Malta | Tajikistan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100.0% | 31.5% | 68.5% | Malta |
| 2010s | 100.0% | 91.0% | 9.0% | Malta |
| 2020s | 100.0% | 99.3% | 0.7% | Malta |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Malta or Tajikistan?
- Malta, at 100.0% against 100.0% in Tajikistan as of 2023.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Malta and Tajikistan?
- 0.0%, with Malta ahead.
- How many years of comparable data are there for Malta and Tajikistan?
- 6 years are reported by both, from 2007 to 2023.
- How do Malta and Tajikistan rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Malta ranks 1st and Tajikistan ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.